Status:
WITHDRAWN
P-Co-Li (Pulmonary Covid-19 Study)
Lead Sponsor:
Northwell Health
Conditions:
Covid19
Lung Inflammation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine whether the use of steroids versus watchful waiting improves pulmonary function tests in patients with history of COVID 19 infection who have residual hypoxemia a...
Detailed Description
Rationale: The long-term pulmonary effects of COVID-19 infection have not been characterized. Many of the patients that have recovered from the initial infection still experience respiratory symptoms,...
Eligibility Criteria
Inclusion
- Outpatients age\>18 with PCR positive COVID19 at least 4-weeks prior;
- persistent opacities (GGO and/or reticular changes) on any chest imaging at least 4-weeks after positive COVID PCR;
- HYPOXEMIA as defined by any of the below:
- Or patient already on supplemental oxygen
- Or room air saturation 94% or less
Exclusion
- age \<18
- special populations (minors, pregnant women, decisional impairment which prevents them from making their own health decisions)
- subjects with underlying ILD pre-COVID19 infection
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04782700
Start Date
April 1 2021
End Date
June 8 2021
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwell Health
Manhasset, New York, United States, 11030